These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 23426500)

  • 1. Worsening of bullous pemphigoid following bacillus Calmette-Guérin treatment for bladder cancer.
    Johnson JL; West DA; Travers JB
    JAMA Dermatol; 2013 Feb; 149(2):248-9. PubMed ID: 23426500
    [No Abstract]   [Full Text] [Related]  

  • 2. Perianal abscess as a complication of intravesical administration of bacillus Calmette-Guerin for bladder cancer.
    Köksal AS; Bilge Z; Torun S; Saşmaz N; Yazicioğlu AH
    Acta Gastroenterol Belg; 2013 Jun; 76(2):260. PubMed ID: 23898568
    [No Abstract]   [Full Text] [Related]  

  • 3. [Calmette-Guerin bacillus disseminated infection after intravesical instillation].
    Borré S; Brustia D; Rosa F; Brondolo R; Rizzo G; Garavelli PL
    Recenti Prog Med; 2002 Apr; 93(4):247-8. PubMed ID: 11989131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostatorectal fistula following intravesical bacillus Calmette-Guérin immunotherapy for carcinoma in situ of the urinary bladder.
    Enatsu N; Ota T; Ochi A
    Int J Urol; 2010 Sep; 17(9):822-3. PubMed ID: 20727055
    [No Abstract]   [Full Text] [Related]  

  • 5. Safety and efficacy of intravesical bacillus Calmette-Guerin instillations in steroid treated and immunocompromised patients.
    Yossepowitch O; Eggener SE; Bochner BH; Donat SM; Herr HW; Dalbagni G
    J Urol; 2006 Aug; 176(2):482-5. PubMed ID: 16813873
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse reactions related to treatment compliance during BCG maintenance therapy for non-muscle-invasive bladder cancer.
    Miyazaki J; Hinotsu S; Ishizuka N; Naito S; Ozono S; Akaza H; Nishiyama H
    Jpn J Clin Oncol; 2013 Aug; 43(8):827-34. PubMed ID: 23858038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized Controlled Study of the Efficacy, Safety and Quality of Life with Low Dose bacillus Calmette-Guérin Instillation Therapy for Nonmuscle Invasive Bladder Cancer.
    Yokomizo A; Kanimoto Y; Okamura T; Ozono S; Koga H; Iwamura M; Tanaka H; Takahashi S; Tsushima T; Kanayama HO; Akaza H; Shinohara N; Mugiya S; Nomata K; Nakamura T; Naito S
    J Urol; 2016 Jan; 195(1):41-6. PubMed ID: 26307162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Re: Agarwal a et al.: The safety and efficacy of different doses of bacillus Calmette Guerin in superficial bladder transitional cell carcinoma (Urology 2007;70:1075-1078).
    Agrawal MS; Bansal S
    Urology; 2009 Feb; 73(2):450-1. PubMed ID: 19185768
    [No Abstract]   [Full Text] [Related]  

  • 9. An unexpected complication of bacillus Calmette-Guérin therapy.
    Yildiz H; Colin G; Lambert M
    Acta Clin Belg; 2014 Aug; 69(4):312. PubMed ID: 24846180
    [No Abstract]   [Full Text] [Related]  

  • 10. Fatal outcome caused by intravenous infusion of bacille Calmette-Guérin.
    Gul U; Kuzgunbay B; Yaycioglu O
    Urology; 2010 Aug; 76(2):518. PubMed ID: 20579707
    [No Abstract]   [Full Text] [Related]  

  • 11. Mycotic Thoracic Aortic Aneurysm After Intravesical Bacillus Calmette-Guérin Treatment.
    Seastedt KP; Ahmad U; Lau C; Ruggeri-Weigel P; Tsang HC; Hartman BJ; Girardi LN
    Ann Thorac Surg; 2015 Jun; 99(6):2210-2. PubMed ID: 26046881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolated renal tuberculosis following intravesical Bacillus Calmette-Guérin therapy for bladder cancer.
    Wada Y; Sugiyama Y; Kikukawa H; Kuwahara T; Takahashi W; Takamiya T; Ueda S
    Urol Int; 2004; 72(3):257-60. PubMed ID: 15084773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute polyarthritis after bacilli Calmette-Guerin intravesical therapy for bladder carcinoma.
    Moutzouris DA; Manetas S; Mountantonakis SE
    J Clin Rheumatol; 2006 Aug; 12(4):214-5. PubMed ID: 16891934
    [No Abstract]   [Full Text] [Related]  

  • 14. Infectious aortic aneurysms occurring 1 year after bacillus Calmette-Guérin bladder instillation therapy.
    Akita H; Okamura T; Nakane A; Kobayashi T; Yamada K; Tanaka Y
    Int J Urol; 2015 Feb; 22(2):234-5. PubMed ID: 25316101
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple organ failure and granulomatous hepatitis following intravesical bacillus Calmette-Guérin instillation.
    Desmet M; Moubax K; Haerens M
    Acta Clin Belg; 2012; 67(5):367-9. PubMed ID: 23189546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe bacillus Calmette-Guerin cystitis responds to systemic steroids when antituberculous drugs and local steroids fail.
    Wittes R; Klotz L; Kosecka U
    J Urol; 1999 May; 161(5):1568-9. PubMed ID: 10210404
    [No Abstract]   [Full Text] [Related]  

  • 17. Chorioretinitis induced by intravesical Bacillus Calmette-Guérin (BCG) instillations for urinary bladder carcinoma.
    Guex-Crosier Y; Chamot L; Zografos L
    Klin Monbl Augenheilkd; 2003 Mar; 220(3):193-5. PubMed ID: 12664378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancer.
    Lerner SP; Tangen CM; Sucharew H; Wood D; Crawford ED
    J Urol; 2007 May; 177(5):1727-31. PubMed ID: 17437798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bladder and penile lesions with inguinal adenopathy after intravesical Bacillus Calmette-Guerin (BCG) treatment.
    Yates J; Stein B
    Urology; 2007 Dec; 70(6):1223.e15-7. PubMed ID: 18158061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bilateral parotid glands infection caused by Calmette-Guerin Bacillus after intravesical therapy for recurrent bladder cancer: a case report.
    Friedlander E; Martínez Pascual P; Montilla de Mora P; Scola Yurrita B
    Braz J Otorhinolaryngol; 2017; 83(6):726-729. PubMed ID: 26923828
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.